Cargando…
CRISPR/Cas9-Mediated CtBP1 Gene Editing Enhances Chemosensitivity and Inhibits Metastatic Potential in Esophageal Squamous Cell Carcinoma Cells
Innovative therapeutic strategies for esophageal squamous cell carcinoma (ESCC) are urgently required due to the limited effectiveness of standard chemotherapies. C-Terminal Binding Protein 1 (CtBP1) has been implicated in various cancers, including ESCC. However, the precise expression patterns and...
Autores principales: | Akhtar, Javed, Imran, Muhammad, Wang, Guanyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530806/ https://www.ncbi.nlm.nih.gov/pubmed/37762332 http://dx.doi.org/10.3390/ijms241814030 |
Ejemplares similares
-
CtBP2 proteome: Role of CtBP in E2F7-mediated repression and cell proliferation
por: Zhao, Ling-Jun, et al.
Publicado: (2014) -
DNA methylation is involved in the pathogenesis of osteoarthritis by regulating CtBP expression and CtBP-mediated signaling
por: Sun, Xiangxiang, et al.
Publicado: (2020) -
Role of the unique N-terminal domain of CtBP2 in determining the subcellular localisation of CtBP family proteins
por: Bergman, Lee M, et al.
Publicado: (2006) -
CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/β-catenin pathway
por: Ju, Qianqian, et al.
Publicado: (2022) -
NSM00158 Specifically Disrupts the CtBP2-p300 Interaction to Reverse CtBP2-Mediated Transrepression and Prevent the Occurrence of Nonunion
por: Chen, Xun, et al.
Publicado: (2020)